logo
Share SHARE
FONT-SIZE Plus   Neg

Covidien Wins $176.5 Mln In Patent Litigation Against Ethicon Endo-Surgery

Healthcare products provider, Covidien (COV) announced that it has won a patent infringement suit against Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, relating to Ethicon's Harmonic line of ultrasonic surgical products.

The company said that the federal court awarded it a $176.5 million verdict upon ruling that several claims of it's patents were valid, enforceable, and infringed by Ethicon. The amount of the verdict, which could be appealed, was based on an 8 percent royalty rate on infringing sales through March 2012, plus prejudgment interest.


The federal court found that Ethicon infringed Covidien's U.S. Patents 6,063,050, 6,468,286, and 6,682,544, each relating to ultrasonic cutting and coagulation surgical devices.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Frozen hash browns, made by McCain Foods USA, are being recalled from stores in nine states, citing that the potatoes may contain extraneous golf ball materials. The product is sold and distributed under the Roundy's and Harris Teeter retail brands. Swiss drug giant Novartis AG reported Tuesday a decline in its first-quarter net profit with weak sales mainly due to negative impact of generic competition and pricing. However, core earnings per share topped analysts' estimates. Further, the company backed its fiscal 2017 forecast. Novartis shares were gaining around 3 percent in the morning trading in Zurich. German business software maker SAP AG on Tuesday reported lower profit in its first-quarter mainly due to higher expenses, despite higher revenues. Further, the company reiterated its outlook for fiscal year 2017. Luka Mucic, CFO, said, "We're off to a good start to reach our full year targets and we are confident that we will grow our profitability in 2018 and beyond."
comments powered by Disqus
Follow RTT